HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maher Albitar Selected Research

HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)

5/2010Clinical correlation of circulating heat shock protein 70 in acute leukemia.
2/2009Circulating heat shock protein 70 and progression in patients with chronic myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maher Albitar Research Topics

Disease

36Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020 - 01/2002
30Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2020 - 01/2002
29B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2021 - 02/2002
26Neoplasms (Cancer)
01/2022 - 01/2002
22BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2016 - 03/2002
22Leukemia
01/2016 - 03/2002
16Hematologic Neoplasms (Hematological Malignancy)
01/2016 - 01/2002
12Lymphoma (Lymphomas)
01/2021 - 02/2002
11Multiple Myeloma
06/2011 - 03/2003
10Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2019 - 06/2002
9Primary Myelofibrosis (Myelosclerosis)
01/2017 - 09/2002
7Myeloproliferative Disorders (Myeloproliferative Disorder)
03/2011 - 09/2002
6Disease Progression
01/2017 - 12/2003
5Chromosome Aberrations (Chromosome Abnormalities)
01/2022 - 08/2002
5Hematologic Diseases (Blood Diseases)
04/2011 - 03/2003
5Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
05/2008 - 02/2002
5Fatigue
09/2006 - 04/2003
4Prostatic Neoplasms (Prostate Cancer)
08/2020 - 03/2014
4Infections
10/2008 - 05/2002
4Anemia
05/2006 - 03/2002
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
03/2022 - 01/2021
3Cytopenia
12/2020 - 05/2006
3Blast Crisis (Blast Phase)
12/2008 - 05/2002
3Hodgkin Disease (Hodgkin's Disease)
02/2007 - 03/2004
3Non-Hodgkin Lymphoma (Lymphosarcoma)
02/2007 - 03/2004
3Philadelphia Chromosome
06/2006 - 05/2002
3Pain (Aches)
04/2004 - 04/2003
3Headache (Headaches)
01/2004 - 04/2003
3Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
06/2003 - 06/2002
2Aplastic Anemia (Anemia, Hypoplastic)
12/2020 - 01/2020
2Thrombocytopenia (Thrombopenia)
12/2020 - 05/2006
2Lung Neoplasms (Lung Cancer)
03/2018 - 01/2011
2Breast Neoplasms (Breast Cancer)
07/2011 - 11/2008
2Anorexia
06/2011 - 09/2006
2Neutropenia
06/2011 - 05/2006
2Hepatocellular Carcinoma (Hepatoma)
04/2011 - 04/2011
2Liver Diseases (Liver Disease)
04/2011 - 04/2011
2Myeloid Leukemia (Leukemia, Myelocytic)
08/2009 - 04/2004
2T-Cell Leukemia (Leukemia, T Cell)
05/2008 - 09/2006
2Diarrhea
09/2006 - 04/2003

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
04/2011 - 03/2002
13Imatinib Mesylate (Gleevec)FDA Link
10/2016 - 05/2002
11Biomarkers (Surrogate Marker)IBA
08/2020 - 06/2002
11Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2007 - 03/2002
10DNA (Deoxyribonucleic Acid)IBA
03/2022 - 02/2003
9Cytarabine (Cytosar-U)FDA LinkGeneric
11/2009 - 05/2002
7Monoclonal AntibodiesIBA
01/2007 - 02/2002
7Rituximab (Mabthera)FDA Link
06/2005 - 02/2002
6Proteasome Endopeptidase Complex (Proteasome)IBA
12/2013 - 03/2008
6fludarabineIBA
06/2005 - 05/2002
5RNA (Ribonucleic Acid)IBA
03/2022 - 01/2007
5Biological ProductsIBA
01/2022 - 08/2002
5UbiquitinIBA
12/2013 - 03/2008
5CytokinesIBA
05/2009 - 08/2002
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2008 - 08/2002
5Pharmaceutical PreparationsIBA
09/2006 - 02/2002
5EnzymesIBA
05/2006 - 01/2002
4Thrombopoietin ReceptorsIBA
12/2020 - 01/2011
4Phosphotransferases (Kinase)IBA
10/2016 - 07/2004
4Indicators and Reagents (Reagents)IBA
10/2010 - 05/2006
4laromustine (VNP40101M)IBA
11/2009 - 11/2005
4Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
07/2007 - 08/2003
4Alkylating AgentsIBA
01/2007 - 05/2002
4Alemtuzumab (Campath)FDA Link
01/2007 - 05/2002
4Thalidomide (Thalomid)FDA Link
05/2006 - 03/2003
4AntigensIBA
12/2003 - 02/2002
3Cell-Free Nucleic AcidsIBA
01/2022 - 01/2016
3Thrombopoietin (c-mpl Ligand)IBA
12/2020 - 08/2006
3Messenger RNA (mRNA)IBA
08/2020 - 02/2007
3Formaldehyde (Formol)FDA Link
07/2011 - 11/2008
3ParaffinIBA
07/2011 - 11/2008
3tanespimycin (17AAG)IBA
06/2011 - 08/2010
3TOR Serine-Threonine KinasesIBA
05/2008 - 11/2005
3Hemoglobins (Hemoglobin)IBA
05/2006 - 10/2002
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2005 - 04/2003
3Gemtuzumab (Mylotarg)FDA Link
06/2005 - 03/2003
3Semaxinib (SU5416)IBA
07/2004 - 08/2003
3Telomerase (Telomerase Reverse Transcriptase)IBA
07/2004 - 03/2003
2ibrutinibIBA
01/2021 - 01/2017
2eltrombopagFDA Link
12/2020 - 01/2020
2Tyrosine Kinase InhibitorsIBA
10/2016 - 09/2003
2Bortezomib (Velcade)FDA Link
06/2011 - 08/2010
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
05/2010 - 03/2002
2HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
05/2010 - 02/2009
2Immunoglobulins (Immunoglobulin)IBA
12/2009 - 12/2003
2A-Form DNA (A-DNA)IBA
08/2009 - 06/2009
2DecitabineFDA Link
08/2009 - 04/2006
2Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
06/2009 - 08/2006
2Caspase 3 (Caspase-3)IBA
05/2009 - 06/2002
2ridaforolimusIBA
05/2008 - 11/2005
2Surface Antigens (Surface Antigen)IBA
01/2007 - 01/2007
2AntibodiesIBA
01/2007 - 09/2004
2EverolimusFDA Link
09/2006 - 11/2005
2Interleukin-6 (Interleukin 6)IBA
08/2005 - 09/2002
2Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
05/2004 - 07/2002
2tipifarnib (R115777)IBA
04/2004 - 03/2003
2TransferasesIBA
04/2004 - 03/2003

Therapy/Procedure

29Therapeutics
01/2021 - 03/2002
5Drug Therapy (Chemotherapy)
07/2009 - 03/2002
2Drug Tapering
05/2006 - 04/2004